HUMAN BIOSPECIMENS

“Inventory Lists”

Often Requested by our clients; likely because other vendors buy and re-sell tissue and aggregate an inventory into a ”list” or Excel sheet.

• Such companies are often brokers – buying/reselling tissues.

• Such samples are often derived from second and third world countries.

• Avaden has access to more than 35,000,000 surgeries, many of which have more than 350 data points from 10-15 years of patient history.

• It would be impossible to aggregate this information into a list.

• EMRs at our clinics are heterogenous and the scale of the data is too large.

• We’d rather ask for detailed customer specifications, which we match against our millions of EMR records to find matches.

• All samples are US-derived under CLIA/CAP protocols and guaranteed to meet customer specifications.

Country of Origin

• Samples are derived from US sources have embedded protections through US Federal Law / HHS (HIPAA).

• Avaden is required to administer consent processes and ensure IRB approved protocols at every clinic with annual renewals.

• Samples derived from second and third world countries have no such statutes to protect patients and are often devoid of any ethical protections.

Pre-analytics

• Can the vendor verify the pre-analytics, which are crucial for molecular assays and validation?  Oftentimes, no, since they don’t have access to the actual clinic.

• Avaden establishes the research protocol inside CLIA and CAP accredited US facilities with rigid protocols, storage, and sample monitoring.